| scholarly article | Q13442814 |
| P2093 | author name string | Andrea J Tenner | |
| Minhan L Dinh | |||
| Francisca Benavente | |||
| Marie E Benoit | |||
| Michael X Hernandez | |||
| Osvaldo Vasquez | |||
| P2860 | cites work | Isolation of three novel human genes encoding G protein-coupled receptors | Q24310837 |
| Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1 | Q24336718 | ||
| Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation | Q24791689 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| AP-1 functions upstream of CREB to control synaptic plasticity in Drosophila | Q28215844 | ||
| The classical complement cascade mediates CNS synapse elimination | Q28261273 | ||
| Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth | Q28287064 | ||
| Common mechanisms of amyloid oligomer pathogenesis in degenerative disease | Q28297615 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
| Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. | Q44241464 | ||
| Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures | Q44737001 | ||
| Neuronal localization of C1q in preclinical Alzheimer's disease | Q44748605 | ||
| Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. | Q44752355 | ||
| Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. | Q45949462 | ||
| Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q. | Q46769124 | ||
| Immunocytochemistry and quantification of protein colocalization in cultured neurons | Q46891143 | ||
| A genome screen of successful aging without cognitive decline identifies LRP1B by haplotype analysis | Q48006562 | ||
| Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation. | Q53214530 | ||
| Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. | Q53233510 | ||
| PDZ Protein Interactions Underlying NMDA Receptor-Mediated Excitotoxicity and Neuroprotection by PSD-95 Inhibitors | Q57083899 | ||
| Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies | Q57089602 | ||
| Purification and radiolabeling of human C1q | Q70831006 | ||
| Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images | Q79854275 | ||
| MatInspector and beyond: promoter analysis based on transcription factor binding sites | Q29616314 | ||
| Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance | Q30274556 | ||
| Afferent deprivation elicits a transcriptional response associated with neuronal survival after a critical period in the mouse cochlear nucleus | Q30490108 | ||
| Toxic fibrillar oligomers of amyloid-β have cross-β structure | Q30514124 | ||
| NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components | Q30576000 | ||
| C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production | Q33601747 | ||
| Collagen VI protects neurons against Abeta toxicity | Q33616790 | ||
| Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking | Q33649821 | ||
| The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration | Q33685823 | ||
| The CREB/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death | Q33908467 | ||
| The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein | Q33949139 | ||
| Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease | Q33999537 | ||
| The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production | Q34318694 | ||
| CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease | Q34450215 | ||
| Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease | Q34550347 | ||
| Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma | Q34755301 | ||
| Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism | Q35139418 | ||
| Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling | Q35610059 | ||
| Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. | Q35981460 | ||
| Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers | Q36178075 | ||
| CREB, synapses and memory disorders: past progress and future challenges | Q36304863 | ||
| Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis | Q36375901 | ||
| Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions | Q36565247 | ||
| LRP in amyloid-beta production and metabolism | Q36690854 | ||
| Functional role of lipoprotein receptors in Alzheimer's disease | Q37089898 | ||
| Expression of complement system components during aging and amyloid deposition in APP transgenic mice | Q37443394 | ||
| Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice | Q38308416 | ||
| Acquisition of chemiluminescent signals from immunoblots with a digital single-lens reflex camera | Q39902264 | ||
| Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. | Q39957275 | ||
| Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. | Q40045324 | ||
| Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes | Q40185662 | ||
| Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein. | Q40459820 | ||
| PAINT: A Promoter Analysis and Interaction Network Generation Tool for Gene Regulatory Network Identification | Q40622156 | ||
| Complement subcomponent C1q stimulates Ig production by human B lymphocytes | Q41683610 | ||
| BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV. | Q41910478 | ||
| CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system. | Q42493783 | ||
| Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling | Q42719378 | ||
| Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression | Q42719812 | ||
| Repeat-induced gene silencing in mammals. | Q44031048 | ||
| Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. | Q44213498 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| neurotoxicity | Q3338704 | ||
| P304 | page(s) | 654-665 | |
| P577 | publication date | 2012-11-13 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity | |
| P478 | volume | 288 |
| Q37093902 | A dramatic increase of C1q protein in the CNS during normal aging. |
| Q35957099 | Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease |
| Q43075623 | An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors |
| Q36620401 | Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function |
| Q35539015 | Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats. |
| Q39985747 | Association Between Microglia, Inflammatory Factors, and Complement with Loss of Hippocampal Mossy Fiber Synapses Induced by Trimethyltin |
| Q41465460 | Autophagy is involved in oral rAAV/Aβ vaccine-induced Aβ clearance in APP/PS1 transgenic mice. |
| Q39341140 | C1q and HMGB1 reciprocally regulate human macrophage polarization |
| Q39364237 | C1q: A fresh look upon an old molecule |
| Q42323104 | C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta |
| Q38957574 | Calreticulin contributes to C1q-dependent recruitment of microglia in the leech Hirudo medicinalis following a CNS injury |
| Q40306336 | Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain |
| Q39251180 | Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity |
| Q35536219 | Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration |
| Q26782203 | Complement activation in the context of stem cells and tissue repair |
| Q37391481 | Complement and microglia mediate early synapse loss in Alzheimer mouse models. |
| Q34341409 | Complement modulation of T cell immune responses during homeostasis and disease. |
| Q35164094 | Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo |
| Q85959086 | Complement--tapping into new sites and effector systems |
| Q59791994 | Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease |
| Q90587392 | Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease |
| Q38542827 | Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease |
| Q36972852 | Fundamental role of C1q in autoimmunity and inflammation |
| Q56482919 | GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol |
| Q89658357 | GPR6 Structural Insights: Homology Model Construction and Docking Studies |
| Q88998664 | Human Cord Blood Serum-Derived APP α-Secretase Cleavage Activity is Mediated by C1 Complement |
| Q43104143 | Immunity and inflammation in neurodegenerative diseases |
| Q30573013 | Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation |
| Q39454075 | Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia |
| Q38916635 | Microglia and Monocyte-Derived Macrophages in Stroke |
| Q28074099 | Microglia communication: Parallels between aging and Alzheimer's disease |
| Q38667336 | Microglia-Mediated Inflammation and Neurodegenerative Disease |
| Q38280315 | Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice |
| Q33821505 | New insights on the role of microglia in synaptic pruning in health and disease |
| Q63916938 | New tricks for an ancient system: Physiological and pathological roles of complement in the CNS |
| Q91652181 | Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer's Disease |
| Q41708233 | Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss |
| Q35662879 | RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. |
| Q94545415 | TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease |
| Q26781815 | The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease |
| Q28086874 | The ischemic environment drives microglia and macrophage function |
| Q64067670 | Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System |
| Q47698731 | Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12. |
| Q35532413 | Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease. |
| Q34471200 | Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis |
| Q37368120 | What does complement do in Alzheimer's disease? Old molecules with new insights |
| Q64119031 | and modify age-at-onset in familial amyloid polyneuropathy patients |
Search more.